Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

PURPOSE: In a recently completed 3-year, randomized, double-blind study, denosumab, a fully human monoclonal antibody against receptor activator of nuclear factor κB ligand, significantly increased bone mineral density and decreased new vertebral fractures in men receiving androgen deprivation thera...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Smith, Matthew R., Saad, Fred, Egerdie, Blair, Szwedowski, Maciej, Tammela, Teuvo L. J., Ke, Chunlei, Leder, Benjamin Z., Goessl, Carsten
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2009
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2900763/
https://ncbi.nlm.nih.gov/pubmed/19836774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2009.08.048
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge